Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lacy

Showing results (181-190 of 553) with videos related to

Pageof 56
Sort By:
The American Journal of Surgical Pathology|January 1, 1982
Alveolar soft-part sarcoma--A malignant angioreninoma: Histochemical, immunocytochemical, and electron-microscopic study of four casesK DeSchryver-Kecskemeti, F T Kraus, W Engleman, et al.
Diabetologia|December 1, 1975
Effect of methylxanthines on alloxan inhibition of insulin releaseP E Lacy, M L McDaniel, C J Fink, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1989
In vivo priming of helper T cells in the absence of B cell activationB S Fox, D Dordai, R L Moore, et al.
Expert Opinion on Pharmacotherapy|November 13, 2015
Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?Brooks D Cash, Brian E Lacy, Tharaknath Rao, et al.
Diabetes|August 1, 1982
Transplantation of islet cells across major histocompatibility barriers after total lymphoid irradiation and infusion of allogeneic bone marrow cellsL D Britt, D W Scharp, P E Lacy, et al.
Clinical and Experimental Immunology|August 1, 1976
Pancreatic lesions induced in rabbits and guinea-pigs with pancreatic antigensP H Wright, R L Gingerich, S King, et al.
Therapeutic Advances in Gastroenterology|May 19, 2018
Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpointBrian E Lacy, Jean Paul Nicandro, Emil Chuang, et al.
Gastroenterology & Hepatology|November 1, 2024
Clarifying the Hazy Concepts of Food Allergies and SensitivitiesLauren Loeb, David C Cangemi, Jacqueline D Squire, et al.
The American Journal of Pathology|December 1, 1979
Studies of the functional and morphologic status of islets maintained at 24 C for four weeks in vitroJ Ono, P E Lacy, H E Michael, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988
Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 miceJ R Wright, J B Lefkowith, G Schreiner, et al.
Pageof 56

Showing results (181-190 of 553) with videos related to

Sort By:
Pageof 56
The American Journal of Surgical Pathology|January 1, 1982
Alveolar soft-part sarcoma--A malignant angioreninoma: Histochemical, immunocytochemical, and electron-microscopic study of four casesK DeSchryver-Kecskemeti, F T Kraus, W Engleman, et al.
Diabetologia|December 1, 1975
Effect of methylxanthines on alloxan inhibition of insulin releaseP E Lacy, M L McDaniel, C J Fink, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1989
In vivo priming of helper T cells in the absence of B cell activationB S Fox, D Dordai, R L Moore, et al.
Expert Opinion on Pharmacotherapy|November 13, 2015
Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?Brooks D Cash, Brian E Lacy, Tharaknath Rao, et al.
Diabetes|August 1, 1982
Transplantation of islet cells across major histocompatibility barriers after total lymphoid irradiation and infusion of allogeneic bone marrow cellsL D Britt, D W Scharp, P E Lacy, et al.
Clinical and Experimental Immunology|August 1, 1976
Pancreatic lesions induced in rabbits and guinea-pigs with pancreatic antigensP H Wright, R L Gingerich, S King, et al.
Therapeutic Advances in Gastroenterology|May 19, 2018
Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpointBrian E Lacy, Jean Paul Nicandro, Emil Chuang, et al.
Gastroenterology & Hepatology|November 1, 2024
Clarifying the Hazy Concepts of Food Allergies and SensitivitiesLauren Loeb, David C Cangemi, Jacqueline D Squire, et al.
The American Journal of Pathology|December 1, 1979
Studies of the functional and morphologic status of islets maintained at 24 C for four weeks in vitroJ Ono, P E Lacy, H E Michael, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988
Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 miceJ R Wright, J B Lefkowith, G Schreiner, et al.
Pageof 56